Professor of Nursing at Columbia University, USA
Maureen George, Ph.D., RN, AE-C, FAAN is Professor of Nursing at Columbia University School of Nursing, Assistant Dean for Scholarship & Research, and Director of the PhD Program. Dr. George has an ongoing program of research focusing on the use of a brief shared decision-making intervention to improve asthma outcomes in federally qualified health centers (FQHC) (R01 NR019275 PI George). This 5-year study, funded for $2.45 million, aims to test the efficacy of BREATHE (BRief intervention to Evaluate Asthma THErapy), a brief shared decision-making intervention that uses motivational interviewing to enhance asthma self-management, to a dose-matched attention control condition. The trial will enroll 200 Black adults with uncontrolled asthma from four FQHCs in the New York metro area. This efficacy-implementation trial uses community-based participatory research to inform the design, testing and evaluation of a behavioral intervention to reduce health inequities in vulnerable populations with chronic respiratory disease. She was recently awarded an administrative supplement Contextualizing Asthma Self-Management with Measures of Indoor Air Quality for Black Adults with Uncontrolled Asthma (3R01NR019275-02S1) to explore indoor air quality in New York City apartments where Black adults with uncontrolled asthma reside.
Additional projects include a study of asthma self-management shared decision-making among Black and Hispanic caregivers-early adolescents with uncontrolled asthma-FQHC primary care providers (1R21NR019668 MPIs George [contact PI] & Bruzzese). Dr. George is also funded to conduct a pilot study of symptom self-management shared decision-making for caregivers and patients with advanced lung disease (P20NR018072-03 (Stone/Shang).
In 2022, she was reappointed to the United Nations Environmental Program’s Medical Technical Options Committee which prepares assessments for the Parties of the Montreal Protocol. This committee reviews the current state of knowledge of technical, scientific, environmental, and economic issues as relates to reducing ozone depletion caused by metered dose inhalers and other medical aerosols. Together, these efforts reflect her interest in behavioral and technological interventions that address the burden of gene-environment interactions in vulnerable populations.Back